Jacqueline N Njenga, NP
Nurse Practitioner · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 17 years
- University of Washington School of Medicine, 2009
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Jacqueline N Njenga’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence C21745 · Deceased
Licence status: Deceased · since 1960 · University of Illinois College of Medicine.
Licensee is deceased.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$11,084
Medicare paid this office $11,084 for 24 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 19 | $6,728 | $99 |
| Psychotherapy with evaluation and management visit, 30 minutes | 18 | $2,596 | $55 |
Who their Medicare patients are
24 Original Medicare patients in 2024. Average age 64 · 85 and older 0% · Health risk score 1.66. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: Depression 71% · High blood pressure 54%.
The office billed $52,810, Medicare allowed $14,546 and paid $11,084; for 133 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 24 | 133 | 64 | 1.66 | $52,810 | $11,084 |
| 2023 | 35 | 344 | 61 | 1.70 | $123,286 | $21,194 |
| 2022 | 39 | 322 | 61 | 1.73 | $121,125 | $18,455 |
| 2021 | 58 | 494 | 62 | 1.14 | $187,231 | $30,236 |
| 2020 | 48 | 496 | 63 | 1.13 | $204,925 | $28,586 |
| 2019 | 33 | 177 | 63 | 1.09 | $83,685 | $12,460 |
| 2018 | 44 | 239 | 62 | 0.99 | $20,962 | $10,389 |
| 2017 | 52 | 277 | 61 | 1.20 | $34,877 | $13,545 |
| 2016 | 40 | 139 | 59 | 1.06 | $23,117 | $6,706 |
| 2015 | 60 | 275 | 63 | 1.28 | $52,931 | $16,373 |
| 2014 | 61 | 186 | 58 | 1.29 | $38,554 | $11,780 |
| 2013 | 33 | 158 | 59 | 0.92 | $30,245 | $7,546 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 28 | $11,198 | $101 |
| Psychotherapy with evaluation and management visit, 30 minutes | 17 | $3,167 | $53 |
| Telehealth originating site facility fee | 35 | $2,879 | $22 |
2022: 3 services
| Return visit (30+ min) | 34 | $11,348 | $92 |
| Telehealth originating site facility fee | 38 | $2,681 | $20 |
| Psychotherapy with evaluation and management visit, 30 minutes | 11 | $2,046 | $52 |
2021: 5 services
| Return visit (30+ min) | 47 | $17,625 | $100 |
| Telehealth originating site facility fee | 57 | $4,268 | $21 |
| New patient visit (60+ min) | 18 | $3,071 | $171 |
| Psychotherapy with evaluation and management visit, 30 minutes | 21 | $2,634 | $52 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 21 | $609 | $26 |
2020: 4 services
| Return visit (30+ min) | 44 | $14,854 | $81 |
| Psychotherapy with evaluation and management visit, 30 minutes | 22 | $4,158 | $55 |
| Telehealth originating site facility fee | 43 | $3,719 | $21 |
| New patient visit (60+ min) | 15 | $2,377 | $158 |
2019: 2 services
| Return visit (30+ min) | 27 | $6,565 | $89 |
| Short return visit (20+ min) | 15 | $789 | $34 |
2018: 3 services
| Short return visit (20+ min) | 35 | $5,438 | $35 |
| Psychotherapy with evaluation and management visit, 45 minutes | 12 | $2,152 | $58 |
| Psychotherapy with evaluation and management visit, 30 minutes | 14 | $1,315 | $47 |
2017: 4 services
| Short return visit (20+ min) | 37 | $4,590 | $36 |
| Psychotherapy with evaluation and management visit, 30 minutes | 22 | $2,418 | $47 |
| Return visit (30+ min) | 25 | $2,242 | $53 |
| New patient visit (45+ min) | 11 | $938 | $85 |
2016: 2 services
| Return visit (30+ min) | 31 | $3,393 | $46 |
| Psychotherapy with evaluation and management visit, 30 minutes | 18 | $1,398 | $41 |
2015: 3 services
| Return visit (30+ min) | 43 | $9,884 | $55 |
| Psychotherapy with evaluation and management visit, 30 minutes | 27 | $2,746 | $48 |
| New patient visit (60+ min) | 20 | $2,423 | $121 |
2014: 4 services
| Return visit (30+ min) | 38 | $5,095 | $56 |
| New patient visit (60+ min) | 24 | $2,706 | $113 |
| Psychotherapy with evaluation and management visit, 30 minutes | 20 | $2,227 | $46 |
| Long return visit (40+ min) | 13 | $1,104 | $69 |
2013: 4 services
| Return visit (30+ min) | 20 | $3,097 | $47 |
| New patient visit (60+ min) | 12 | $1,300 | $108 |
| Psychotherapy with evaluation and management visit, 30 minutes | 11 | $1,179 | $25 |
| Psychiatric diagnostic evaluation with medical services | 15 | $888 | $59 |
Drugs they prescribed that Part D paid
$27,039
Pharmacies billed $27,039 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 272) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
261 generic and 11 brand-name prescriptions · $27,039 in drug cost · 28 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ziprasidone | 11 | $2,194 | $199 |
| Quetiapine | 12 | $840 | $70 |
| Venlafaxine Hcl Er | 20 | $604 | $30 |
| Fluoxetine | 18 | $543 | $30 |
| Bupropion Xl | 20 | $533 | $27 |
See all 10 drugs
| Ziprasidone | 11 | $2,194 | $199 |
| Quetiapine | 12 | $840 | $70 |
| Venlafaxine Hcl Er | 20 | $604 | $30 |
| Fluoxetine | 18 | $543 | $30 |
| Bupropion Xl | 20 | $533 | $27 |
| Hydroxyzine | 11 | $520 | $47 |
| Buspirone | 14 | $433 | $31 |
| Escitalopram | 14 | $278 | $20 |
| Sertraline | 16 | $208 | $13 |
| Lamotrigine | 16 | $71 | $4 |
Year by year
| 2024 | 272 | 26 | 0% (0) | 4% | $27,039 |
| 2023 | 334 | 35 | 0% (0) | 4% | $33,718 |
| 2022 | 425 | 41 | 0% (0) | 3% | $54,638 |
| 2021 | 480 | 51 | 0% (0) | 3% | $41,344 |
| 2020 | 472 | 41 | 0% (0) | 7% | $33,451 |
| 2019 | 372 | 40 | 0% (0) | 4% | $23,427 |
| 2018 | 521 | 43 | 0% (0) | 3% | $30,370 |
| 2017 | 555 | 48 | 0% (0) | None | $34,616 |
| 2016 | 394 | 40 | 0% (0) | None | $44,112 |
| 2015 | 456 | 55 | 0% (0) | 8% | $49,800 |
| 2014 | 437 | 59 | 0% (0) | 15% | $70,938 |
| 2013 | 287 | 24 | 0% (0) | 21% | $36,081 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Venlafaxine Hcl Er | 29 | $1,141 | $39 |
| Quetiapine | 15 | $907 | $60 |
| Fluoxetine | 19 | $514 | $27 |
| Bupropion Xl | 35 | $428 | $12 |
| Escitalopram | 16 | $363 | $23 |
| Lamotrigine | 25 | $348 | $14 |
| Sertraline | 21 | $292 | $14 |
| Citalopram Hbr | 17 | $120 | $7 |
2022: 14 drugs
| Clomipramine | 18 | $18,119 | $1,007 |
| Ziprasidone | 20 | $3,652 | $183 |
| Bupropion Xl | 54 | $2,914 | $54 |
| Quetiapine | 24 | $2,633 | $110 |
| Buspirone | 16 | $1,706 | $107 |
| Methylphenidate | 22 | $1,076 | $49 |
| Venlafaxine Hcl Er | 21 | $703 | $33 |
| Fluoxetine | 36 | $502 | $14 |
| Sertraline | 15 | $417 | $28 |
| Lamotrigine | 21 | $368 | $18 |
| Mirtazapine | 16 | $340 | $21 |
| Escitalopram | 15 | $279 | $19 |
| Clonazepam | 12 | $87 | $7 |
| Citalopram Hbr | 19 | $87 | $5 |
2021: 18 drugs
| Clomipramine | 35 | $14,249 | $407 |
| Bupropion Xl | 51 | $2,012 | $39 |
| Duloxetine | 23 | $1,729 | $75 |
| Buspirone | 21 | $1,188 | $57 |
| Fluoxetine | 44 | $1,109 | $25 |
| Quetiapine | 25 | $911 | $36 |
| Ziprasidone | 12 | $797 | $66 |
| Venlafaxine Hcl Er | 16 | $671 | $42 |
| Sertraline | 22 | $355 | $16 |
| Zolpidem | 14 | $348 | $25 |
| Mirtazapine | 12 | $296 | $25 |
| Methylphenidate | 15 | $279 | $19 |
| Escitalopram | 15 | $269 | $18 |
| Nortriptyline | 15 | $205 | $14 |
| Clonazepam | 19 | $143 | $8 |
| Citalopram Hbr | 20 | $108 | $5 |
| Lorazepam | 11 | $94 | $9 |
| Olanzapine | 12 | $73 | $6 |
2020: 17 drugs
| Viibryd | 12 | $6,900 | $575 |
| Vyvanse | 11 | $3,753 | $341 |
| Buspirone | 25 | $2,543 | $102 |
| Duloxetine | 24 | $2,251 | $94 |
| Bupropion Xl | 34 | $1,136 | $33 |
| Fluoxetine | 29 | $905 | $31 |
| Mirtazapine | 23 | $848 | $37 |
| Venlafaxine Hcl Er | 14 | $669 | $48 |
| Quetiapine | 24 | $584 | $24 |
| Escitalopram | 21 | $551 | $26 |
| Sertraline | 19 | $521 | $27 |
| Trazodone | 13 | $318 | $24 |
| Zolpidem | 24 | $210 | $9 |
| Clonazepam | 17 | $180 | $11 |
| Methylphenidate | 13 | $128 | $10 |
| Citalopram Hbr | 16 | $111 | $7 |
| Olanzapine | 14 | $84 | $6 |
2019: 12 drugs
| Bupropion Xl | 38 | $2,545 | $67 |
| Buspirone | 14 | $1,585 | $113 |
| Duloxetine | 26 | $1,268 | $49 |
| Fluoxetine | 32 | $899 | $28 |
| Ziprasidone | 12 | $804 | $67 |
| Aripiprazole | 12 | $780 | $65 |
| Zolpidem | 24 | $468 | $20 |
| Quetiapine | 28 | $362 | $13 |
| Trazodone | 16 | $359 | $22 |
| Sertraline | 13 | $212 | $16 |
| Lamotrigine | 16 | $178 | $11 |
| Citalopram Hbr | 15 | $162 | $11 |
2018: 19 drugs
| Bupropion Xl | 58 | $4,787 | $83 |
| Vyvanse | 12 | $3,822 | $319 |
| Aripiprazole | 28 | $3,804 | $136 |
| Buspirone | 27 | $2,565 | $95 |
| Fluoxetine | 37 | $1,274 | $34 |
| Ziprasidone | 23 | $1,177 | $51 |
| Duloxetine | 13 | $994 | $76 |
| Mirtazapine | 18 | $823 | $46 |
| Escitalopram | 35 | $763 | $22 |
| Quetiapine | 36 | $718 | $20 |
| Zolpidem | 29 | $460 | $16 |
| Venlafaxine Hcl Er | 13 | $449 | $35 |
| Clonazepam | 18 | $398 | $22 |
| Trazodone | 14 | $397 | $28 |
| Lamotrigine | 24 | $273 | $11 |
| Methylphenidate | 12 | $229 | $19 |
| Risperidone | 15 | $144 | $10 |
| Sertraline | 21 | $137 | $7 |
| Citalopram Hbr | 17 | $124 | $7 |
2017: 17 drugs
| Aripiprazole | 28 | $6,055 | $216 |
| Dextroamphetamine Sulfate Er | 11 | $4,610 | $419 |
| Ziprasidone | 29 | $1,756 | $61 |
| Bupropion Xl | 40 | $1,609 | $40 |
| Venlafaxine Hcl Er | 30 | $616 | $21 |
| Quetiapine | 38 | $522 | $14 |
| Escitalopram | 55 | $487 | $9 |
| Zolpidem | 28 | $442 | $16 |
| Lamotrigine | 29 | $409 | $14 |
| Fluoxetine | 40 | $408 | $10 |
| Lithium Carbonate Er | 11 | $397 | $36 |
| Buspirone | 18 | $301 | $17 |
| Mirtazapine | 18 | $200 | $11 |
| Citalopram Hbr | 22 | $166 | $8 |
| Trazodone | 11 | $129 | $12 |
| Clonazepam | 13 | $108 | $8 |
| Lorazepam | 19 | $97 | $5 |
2016: 15 drugs
| Aripiprazole | 23 | $9,674 | $421 |
| Clomipramine | 12 | $6,425 | $535 |
| Ziprasidone | 28 | $3,791 | $135 |
| Bupropion Xl | 34 | $1,457 | $43 |
| Quetiapine | 17 | $501 | $29 |
| Escitalopram | 24 | $499 | $21 |
| Fluoxetine | 15 | $480 | $32 |
| Venlafaxine Hcl Er | 13 | $430 | $33 |
| Lamotrigine | 28 | $361 | $13 |
| Methylphenidate | 11 | $323 | $29 |
| Bupropion Hcl Sr | 12 | $253 | $21 |
| Citalopram Hbr | 24 | $193 | $8 |
| Hydroxyzine Pamoate | 12 | $160 | $13 |
| Divalproex | 12 | $113 | $9 |
| Buspirone | 13 | $76 | $6 |
2015: 23 drugs
| Aripiprazole | 16 | $11,955 | $747 |
| Clomipramine | 11 | $6,868 | $624 |
| Duloxetine | 30 | $5,691 | $190 |
| Ziprasidone | 26 | $3,485 | $134 |
| Viibryd | 11 | $2,081 | $189 |
| Bupropion Xl | 35 | $1,343 | $38 |
| Buspirone | 11 | $762 | $69 |
| Dextroamphetamine-Amphetamine | 12 | $717 | $60 |
| Fluoxetine | 19 | $659 | $35 |
| Mirtazapine | 12 | $432 | $36 |
| Risperidone | 13 | $422 | $32 |
| Methylphenidate | 12 | $403 | $34 |
| Quetiapine | 16 | $375 | $23 |
| Venlafaxine Hcl Er | 14 | $360 | $26 |
| Divalproex | 11 | $265 | $24 |
| Lamotrigine | 21 | $253 | $12 |
| Escitalopram | 16 | $184 | $11 |
| Zolpidem | 16 | $159 | $10 |
| Citalopram Hbr | 30 | $143 | $5 |
| Bupropion Hcl Sr | 14 | $126 | $9 |
| Sertraline | 12 | $96 | $8 |
| Trazodone | 15 | $96 | $6 |
| Clonazepam | 11 | $81 | $7 |
2014: 16 drugs
| Abilify | 28 | $25,485 | $910 |
| Duloxetine | 34 | $11,290 | $332 |
| Ziprasidone | 29 | $6,395 | $221 |
| Quetiapine | 38 | $5,480 | $144 |
| Bupropion Xl | 24 | $1,182 | $49 |
| Olanzapine | 11 | $437 | $40 |
| Lamotrigine | 14 | $416 | $30 |
| Risperidone | 13 | $415 | $32 |
| Methylphenidate | 11 | $388 | $35 |
| Oxcarbazepine | 15 | $377 | $25 |
| Bupropion Hcl Sr | 17 | $340 | $20 |
| Liothyronine | 11 | $297 | $27 |
| Fluoxetine | 17 | $209 | $12 |
| Escitalopram | 16 | $169 | $11 |
| Citalopram Hbr | 23 | $133 | $6 |
| Clonazepam | 12 | $77 | $6 |
2013: 7 drugs
| Abilify | 11 | $8,749 | $795 |
| Ziprasidone | 24 | $5,765 | $240 |
| Quetiapine | 42 | $1,738 | $41 |
| Oxcarbazepine | 18 | $471 | $26 |
| Citalopram Hbr | 13 | $107 | $8 |
| Fluoxetine | 16 | $106 | $7 |
| Clonazepam | 14 | $82 | $6 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1093045395
- Licence
- CA 21745California C21745: Deceased
- Trained
- University of Washington School of Medicine, 2009 · 17 years ago
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 363LP0808X (363LP0808X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2010-01-08
- NPI last updated
- 2025-12-30
- NPI record certified
- 2025-12-30
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 9330 59th Ave Sw, Tacoma, WA, 98499